Financials — KARMANOS CANCER HOSPITAL
3-statement model reconstructed from HCRIS + deal profile
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
Income Statement
| Line Item | Amount |
|---|---|
| Gross Patient Revenue estimated | $632.8M |
| Contractual Allowances estimated | $-348.1M |
| Net Patient Revenue deal_profile | $284.8M |
| Bad Debt Expense benchmark 3% | $-8.5M |
| Total Operating Revenue computed | $276.2M |
| Salaries & Wages benchmark 55% opex | $-144.1M |
| Supplies benchmark 18% opex | $-47.2M |
| Other Operating residual | $-70.7M |
| Total Operating Expenses estimated | $-262.0M |
| EBITDA computed | $14.2M |
| D&A benchmark 4% NPR | $-11.4M |
| EBIT computed | $2.8M |
| Interest benchmark 2% NPR | $-5.7M |
| EBT computed | $-2.8M |
| Taxes 25% rate | $0.0M |
| Net Income computed | $-2.8M |
Balance Sheet
| Line Item | Amount |
|---|---|
| Cash benchmark 45 days | $35.1M |
| A/R deal_profile | $21.7M |
| Inventory benchmark 15 days | $11.7M |
| Other Current benchmark 2% | $5.7M |
| Total Current Assets computed | $74.2M |
| PP&E Net benchmark 60% NPR | $170.9M |
| Other Assets benchmark 5% | $14.2M |
| Total Assets computed | $259.3M |
| A/P benchmark 40 days | $28.7M |
| Accrued Liab benchmark 6% opex | $15.7M |
| Current Debt benchmark 5% total debt | $2.5M |
| Total Current Liab computed | $46.9M |
| LT Debt benchmark 3.5x EBITDA | $47.3M |
| Total Liabilities computed | $94.3M |
| Total Equity plug (A - L) | $165.1M |
| Total L + E computed | $259.3M |
What This Means
This 3-statement model reconstructs the hospital's income statement, balance sheet, and cash flow from HCRIS cost report data. Each line item is tagged with its data source: HCRIS (actual reported), deal_profile (user input), benchmark (industry estimate), computed (derived).
Use this to identify data quality: lines tagged "benchmark" are estimates that should be validated during diligence. Request actual data for these items via diligence questions.
Cash Flow Statement
| Line Item | Amount |
|---|---|
| Net Income computed | $-2.8M |
| + D&A from IS | $11.4M |
| Change in A/R 3% growth | $-0.7M |
| Change in Inventory 2% growth | $-0.2M |
| Change in A/P 2% growth | $0.6M |
| CFO computed | $8.2M |
| CapEx benchmark 4% NPR | $-11.4M |
| CFI computed | $-11.4M |
| Debt Repayment 5% of LT debt | $-2.4M |
| CFF computed | $-2.4M |
| Net Change computed | $-5.5M |
| FCF CFO - CapEx | $-3.2M |